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Abstract 
 
Many epidemiological studies indicate that Mediterranean diet is a 
healthy eating plan useful in protecting against chronic disorders such as 
diabetes, cardiovascular and neurodegenerative ones [1-4]. Its health benefits 
are associated to the high consumption of certain food groups such as 
vegetables, fish, legumes, whole cereals and extra virgin olive oil (EVOO). In 
particular, EVOO, the main source of fat in the Mediterranean diet, has many 
protective effects on health because of its high content in monounsaturated 
fatty acids (MUFAs), as well as in polyphenolic compounds [5]. Among these, 
oleuropein and its derivatives, such as hydroxytyrosol, showed interesting anti-
oxidant and anti-inflammatory properties so that they appeared useful in many 
metabolic and degenerative diseases including diabetes, hypertension, and 
Parkinson’s disease [6-8].  
The aim of the present study was to investigate oleuropein effects on 
microvascular responses. 
First, we investigated the in vivo effects of oleuropein on rat pial 
microcirculation submitted to hypoperfusion-reperfusion injury. Therefore, we 
studied acute microvascular responses such as arteriolar vasodilation, 
permeability increase, leukocyte adhesion and capillary perfusion, by 
fluorescence microscopy. The working hypothesis was that this polyphenol 
may induce nitric oxide (NO) release from endothelial cells and consequently 
protect cerebral blood flow distribution and cerebral tissue. Rat cerebral 
cortical eNOS protein levels were evaluated as well as the impact of oxidative 
stress induced by hypopefusion and reperfusion on brain tissue, utilizing 
DCFH-DA. 
The second part of the study was aimed to evaluate oleuropein effects 
on skin microvascular blood flow oscillations of hyperlipidemic obese patients, 
by laser Doppler flowmetry (LDF). This is a non-invasive technique by which 
the rhythmic oscillations of blood flow in peripheral circulation, the so called 
flowmotion, can be assessed [9]. Moreover, laser Doppler signal analysis 
allows us to receive interesting informations about the influence of heart rate, 
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respiration, intrinsic myogenic activity, neurogenic factors and endothelial 
activities on cutaneous blood flow [10]. 
Therefore, hyperlipidemic obese patients were administered with a 
hypocaloric and hypolipidic diet plus oleuropein for three months. These data 
were compared with the response of hyperlipidemic obese patients 
administered with hypocaloric and hypolipidic diet. Under baseline conditions 
and at the end of the study, nutritional status and lipid profile were evaluated as 
well as skin blood flow oscillations and reactive hyperemia by LDF.  
The results of the experimental study in rats indicate that oleuropein 
significantly improved in vivo microvascular responses after hypoperfusion-
reperfusion injury. In particular, 20 mg/Kg b.w. of oleuropein induced a 
dilation by 28 ±2% of baseline (p < 0.01 vs. I group) in order 3 arterioles and 
significantly reduced microvascular leakage (NGL: 0.13 ± 0.03; p < 0.01 vs. I 
group) as well as leukocyte adhesion on venular walls (2.0 ± 0.5/100 µm 
v.l./30 sec; p < 0.01 vs. I group), at the end of reperfusion. Moreover, this 
polyphenol was able to preserve capillary perfusion at the end of reperfusion  
(-26.0±4.5% of baseline; p<0.01 vs. I group). These responses were associated 
to the increased eNOS expression in cortex and in striatum of treated animals. 
Oleuropein was also able to reduce neuronal damage and ROS production at 
the end of reperfusion, compared with hypoperfused animals.  
On the other hand, the results of the clinical study revealed that three 
months of hypocaloric and hypolipidic diet associated to oleuropein 
significantly improved nutritional status and lipid profile of hyperlipidemic 
obese patients. Total and LDL cholesterol, indeed, decreased by 15.0±1.2 and 
16.5±1.3%, respectively, in patients treated with diet (OD group), and by 
21.3±1.5 and 21.2±1.4%, respectively, in subjects treated with diet plus 
oleuropein (OL group).  
Moreover, laser Doppler measurements showed an increase in skin 
perfusion, compared to baseline conditions and control group (+25.6±1.4% of 
baseline), while the spectral analysis of skin blood flow oscillations revealed an 
increase in the NO-dependent and myogenic-related frequency components. 
Furthermore, PORH response improved in oleuropein-treated group, compared 
to controls.   
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In conclusion, oleuropein appeared able to protect rat pial 
microcirculation from hypoperfusion-reperfusion injury increasing nitric oxide 
release from endothelial cells, reducing oxidative stress and, consequently, 
preserving pial blood flow distribution. Interestingly, this polyphenol showed 
beneficial effects also in humans; three months of hypocaloric and hypolipidic 
diet plus oleuropein increased smooth muscle cell functions and microvascular 
responses in hyperlipidemic obese patients, improving tissue perfusion. 
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Chapter 1 
Introduction 
 
 
1. 1.The Mediterranean Diet 
 
The term “Mediterranean diet” is not only representative of an healthy 
eating plan, well appreciated for its protective effects on health, but includes all 
culture and traditions of Mediterranean populations about harvesting, 
conservation, processing, cooking of foods and, in particular, the way to 
consume it.   
At the beginning of ’50s Ancel Keys (1904-2004), an American 
physiologist, PhD in Biology at the University of Minnesota, USA, was 
interested in studying the correlation between cardiovascular disease and diet 
in the United States, because Americans were dying younger than peoples in 
many other Countries. Keys hypothesized that this phenomenon might depend 
on nutrition and, after interesting conversations with the Prof. Gino Bergami, 
physiologist at the University of Naples, left for the southern of Italy, where 
the myocardial infarction was not as common as in the States.  
Therefore, Keys, with the collaboration of eminent scientists around the 
world, investigated the relationship between Nutrition, Human Physiology and 
Food Culture; it was the Seven Countries Study (SCS).  
During the first phase of the study (1958-1983), standardized lifestyle 
and risk factor surveys were carried out at baseline and after 5 and 10 years of 
follow-up in 16 cohorts of middle-aged men from seven Countries. The second 
phase of the investigation (1984-1999) was characterized by the study of 
cardiovascular disease in elderly populations of 9 European cohorts. 50 year 
mortality data were collected up to 2014 and still are in 13 of the 16 cohorts. 
Fatty acids, contained in foods consumed in their own homes by 
volunteers of the 16 cohorts, were chemically analyzed. Therefore, Ancel Keys 
and colleagues detected interesting associations across cultures in the SCS; 
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different cultures denoted differences in their diets. Moreover, corresponding 
differences were seen in saturated fat, serum cholesterol and coronary heart 
disease (CHD) incidence after 5 and 10 years of follow-up. The data indicated 
that high cholesterol serum levels were associated with a higher risk of 
mortality from cardiovascular disease in the different SCS cohorts. In addition, 
serum levels of cholesterol correlated with coronary heart disease, fatal after 35 
years, although this association decreased with age. Adhering to a 
Mediterranean style diet was associated with a 39% lower coronary mortality 
risk. Thus, a high consumption of bread, pasta, legumes, vegetables, fruit and 
fats rich in unsaturated fatty acids, a moderate intake of fish and a low intake of 
dairy products and meat, characteristic of a Mediterranean Diet, appeared 
essential to prevent cardiovascular damage [11,12,14]. 
In 2010, therefore, UNESCO recognized the Mediterranean Diet as 
Intangible Cultural Heritage of Humanity, defining the Mediterranean Diet “a 
social practice based on the set of skills, knowledge, practices and traditions 
ranging from the landscape to the cuisine, which in the Mediterranean basin 
concern the crops, harvesting, fishing, conservation, processing, preparation 
and, particularly, consumption. This set, recreated within and by the 
communities identified in the territories of the four States Parties (Italy, Spain, 
Greece and Morocco), is unavoidably linked to a seasonal calendar marked by 
nature and religious or ritual meanings” [13]. 
The Mediterranean eating plan is characterized by a daily intake of 
whole cereals, vegetables, legumes, fruit and olive oil; a moderate intake of 
fish and poultry and a lower intake of dairy products, red and processed meats, 
as shown in Figure 1. After Keys studies, many papers investigated the 
association between certain food consumption and chronic diseases such as 
obesity, cancer and diabetes. The Greek EPIC prospective cohort study 
investigated the effects of individual components of Mediterranean diet on the 
overall mortality. The results indicated that dominant components of the 
Mediterranean diet score as a predictor of lower mortality were the moderate 
consumption of ethanol, a low consumption of meat and processed meats, the 
high consumption of vegetables, fruits and nuts, olive oil, and legumes. Low 
contributions were found for cereals, dairy products, fish and seafood [16]. 
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Moreover, the PREDIMED (Prevención con Dieta Mediterránea) study, 
demonstrated that an hypocaloric Mediterranean diet, supplemented with extra-
virgin olive oil resulted in an absolute risk reduction of approximately 3 major 
cardiovascular events per 1000 person-years and a relative risk reduction by 
approximately 30%, among high-risk persons who were initially free of 
cardiovascular disease [17]. Many other studies showed that EVOO 
consumption was associated with a significant reduction of cardiovascular 
disease and mortality in Spanish and Italian populations [18]. 
 
 
 
 
 
 
 
 
 
 
Fig.1: The Mediterranean Diet Pyramid.  
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1.1.1. The olive oil 
 
It is well known that virgin olive oil, the main source of fat in the 
Mediterranean Diet, is obtained by mechanical processes from olives and can 
be directly consumed without any further refining treatment. Its chemical 
composition is characterized by two different fractions: a saponifiable and a 
unsaponifiable fraction [19]. The first represents the 98.5 %-99.5 % of the oil 
chemical composition and is constituted by triacylglycerols, diacylglycerols, 
monoacylglycerols, free fatty acids and phospholipids. Oleic acid (C18:1, n-9) 
is usually the most common monounsaturated fatty acid, even thought fatty 
acids composition depends on different factors, such as latitude, climate and 
maturity of fruits. Italian, Greek and Spanish olive oils, indeed, are 
characterized by a high amount of oleic acid, which is around 70% of total 
fatty acids, while palmitic and linoleic acids are low. Previous studies showed 
that oleic acid was able to reduce cardiovascular risk increasing the high 
density lipoprotein (HDL) and reducing low density lipoprotein (LDL) levels; 
moreover, hypotensive effects were also demonstrated [20-22].   
On the other hand, the unsaponifiable fraction contributes around 1-2 % 
of the oil composition and includes hydrocarbons, tocopherols, coloring 
pigments, sterols, phenols and triterpenes. This fraction contains many 
molecules with antioxidant properties, especially tocopherols and phenolic 
compounds. It is interesting to consider that tocopherols and carotenoids are 
widely diffused in nature, while phenolic substances are exclusively present in 
olive plants and are associated to the sensation of bitterness and pungency in 
oil. The mean amount of hydrophilic phenolic compounds in olive oil depends 
on many technological factors and can vary from 40 to 1000 mg/kg [23,24]. 
These molecules can be classified as phenyl acids, phenyl alcohols, flavonoids, 
secoiridoids and lignans (Fig.1.1). 
In particular, secoiridoids, produced from the secondary metabolism of 
terpenes, are present only in plants of the Oleaceae family. 
Secoiridoids  are glycosylated compounds, characterized by the 
presence of elenolic acid in their structure. In particular, the most abundant 
secoiridoids in olives are oleuropein, demethyloleuropein, ligustroside, while 
nuzenide is mostly abundant in olive seeds. During olive oil production 
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secoiridoids undergo to hydrolysis by endogenous glucosidases, producing 
aglyconic corresponding forms. Therefore, the most abundant secoiridoids in 
olive oil are the dialdehyde form of elenolic acid linked to hydroxytyrosol (3,4-
DHPEA-EDA) or tyrosol (p-HPEA-EDA) [25-30]. 
 
 
 
 
 
                                   Phenolic compounds 
 
 
  
Simple phenols 
Hydroxytyrosol 
Lignans 
(+)-Pinoresinol 
Tyrosol (+)-1-Acetoxypinoresinol 
Vanillic acid  
p-Cumaric Acid Secoiridoids 
Ferulic Acid Glycosilated Oleuropein 
4-Ethylphenol Dimethyloleuropein 
Tyrosyl Acetate Oleuropein 
Hydroxytyrosylacetate Elenolic Acid 
 Ligstroside 
Polyphenols Deacetoxyligstroside 
Flavonoids  
Apigenin  
Luteolin  
 
 
Fig.1.1 : Olive oil phenolic compounds. 
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Many studies investigated the effects of polyphenols-enriched olive oil 
on health. Oliveras-Lopez et al. showed that extra-virgin olive oil rich in 
polyphenols reduces oxidative stress in mice pancreas [31], while Fernández-
Castillejo et al., demonstrated that a polyphenol-rich olive oil enhance olive oil 
benefits, improving lipoprotein subclasses distribution and representing a 
complementary tool for the management of cardiovascular risk [32]. Among 
olive oil polyphenols, oleuropein and its derivatives showed strong antioxidant 
and anti-inflammatory activities [33,34]. 
 
1.1.2. Oleuropein 
 
Oleuropein is an ester of 2-(3,4-dihydroxyphenyl) ethanol derived from 
mevalonic acid pathway (Fig. 1.2, 1.3) [35]. This polyphenolic compound is 
widely distributed in tissues of olive plants. Its concentration appears high in 
olive leafs and fruits, where represent the most abundant phenolic molecule. In 
particular,  in young olives, oleuropein reaches concentrations around 14% of 
dry weight. However, during olive fruits maturation process, oleuropein 
amount significantly change, reaching lower concentrations in black olives. 
The oleuropein decline is due to the enzymatic activity of esterases,  able to 
produce glucosylated derivatives of oleuropein, such as elenolic acid glucoside 
and demethyloleuropein, particularly abundant in black olives [36,37].  
However, its content depends on different conditions such as cultivar, 
ripening stage and geographic origin. In particular, Italian and Greek cultivars 
contain high amount of oleuropein, compared to others [38]. 
Its antioxidant activity is closely related to the chemical structure, in 
which the functional group is an hydroxyl directly bonded to a benzene ring. In 
particular, it has been shown that, hydroxytyrosol (3,4-DHPEA) and 
secoiridoids containing this compound in their molecular structure, such as 
Oleuropein, have a strong antioxidant activity, more effective than vitamin E 
[39]. Therefore, many studies investigated the effects of this polyphenol by in 
vitro and in vivo models. 
Visioli et al. hypothesized that the lower incidence of CHD and cancer, 
associated with the Mediterranean diet, could be related to oleuropein’s 
antioxidant properties demonstrating that this molecule has a scavenger role 
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inhibiting neutrophils respiratory burst [39]. Moreover, he demonstrated that, 
during endotoxin challenge, oleuropein potentiates the macrophage-mediated 
response, resulting in higher NO production [40]. Coni et al. showed that a diet 
enriched with oleuropein was able to reduce LDL oxidation as well as 
plasmatic cholesterol levels in rabbits [41]. Moreover, this polyphenol 
protected isolated rat hearts from ischemia-reperfusion injury reducing creatine 
kinase production and the reduced glutathione release [42]. The anti-
inflammatory properties of oleuropein are mainly related to its ability in 
inhibiting the biosynthesis of pro-inflammatory cytokines such as tumor 
necrosis factor α (TNF-α) and interleukin-1 beta (IL-1β). [43]. Jemai et al. 
demonstrated that oleuropein derivatives improve lipid profile in rats lowering 
total LDL levels and inhibiting LDL oxidation [44]. 
Interestingly, Vissers et al. found that phenolic compounds from virgin 
olive oil, such as oleuropein, are highly bioavailable in humans reaching 
absorption values around 55–60%. Moreover, after oral ingestion, oleuropein 
appeared rapidly absorbed and the maximum plasma concentration occurs 2 h 
after administration [45] 
However, to date, only few studies investigated oleuropein effects in 
humans. In particular, De Bock et al. showed that a diet enriched with olive 
leaf polyphenols was able to improve insulin sensitivity and pancreatic β-cell 
secretory capacity in overweight middle-aged men [46].  
However, there are no data about the specific oleuropein effects on 
human microcirculation.  
 
  
  
Fig.1.2: Oleuropein and oleuropein aglycone structure [47]. 
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Fig.1.3: Oleuropein biosynthetic pathway [47]. 
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1.2.The microcirculation 
 
The microvascular system represents the smallest part of the circulatory 
system, comprising arterioles, capillaries and venules (Fig.1.4). Each portion of 
microvascular bed has intrinsic properties, length and cross-sectional diameter.  
The arterioles are characterized by a layer of endothelial cells 
surrounded by the internal elastic lamina and a multilayered vascular smooth 
muscle and connective coat. Proceeding downstream from arterioles to 
capillaries, it is possible to observe localized groups of smooth muscle cells. 
Smaller arterioles, the so called terminal arterioles, have a mean diameter 
around 10 μm and their important role is the fine regulation of blood flow. The 
activity of arteriole smooth muscle layer is regulated by sympathetic nerve 
fibers, which allow arterioles rapidly changing their tone.  Moreover, gap 
junctions between smooth muscle cells as well as endothelial ones assure cell-
cell communication and coordination of local responses.  
Capillaries are the smallest vessels of microcirculation, with a diameter 
around 4-6 μm. They consist of a simple endothelial layer surrounded by a 
basement membrane and occasional pericytes. The vessels immediately 
following capillaries, the so called post-capillary venules, have a mean 
diameter around 15-25 μm. Vascular smooth muscle is absent in venous 
vessels under 30 µm, allowing the exchange of substances between blood and 
interstitial fluid. The last portion of microvascular tree is characterized by 
collecting venules, larger vessels with contractile properties controlling the 
output flow [48]. 
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            Fig. 1.4: Microvascular network [70]. 
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1.2.1 The role of arterioles 
 
The distribution of blood flow represent a coordinated interplay 
between arteriolar, capillary, and venular segments according to local and 
regional metabolic demand. In turn, mechanisms of flow control reflect the 
functional interactions between skeletal muscle fibers and the respective 
smooth muscle cells, endothelial cells, and neural projections, which comprise 
and regulate the vascular supply. The regulation of muscle blood flow is 
presented in context of the classic Fick relationship, where the consumption of 
oxygen by the mitochondria within muscle fibers reflects the product of 
extraction from the blood and the rate of blood flow through the muscle.  
Arterioles are resistance microvessels enveloped by vascular smooth 
muscle that by contraction or relaxation controls the vessel caliber and thus the 
volume of blood flow. When arterioles dilate, downstream blood flow is 
increased. When arterioles contract, blood flow to the downstream 
microvascular bed (capillaries) is reduced. Arterioles represent the most 
important vascular section in regulating tissue perfusion. They are able, indeed, 
to significantly contract and dilate, representing the primary site of vascular 
resistance. Their diameter, indeed, can change by up to 50% from basal levels 
after certain stimuli. Arterioles respond to many stimuli, such as physical ones: 
an elevated intravascular pressure induces arteriolar constriction, while the 
reduction of blood flow induces a significant arteriolar vasodilation. However, 
arterioles receive a variety of vasoconstrictor and vasodilator stimuli [49]. 
 
 
1.2.2. The vasomotion 
 
Vascular smooth muscle cells show spontaneous and rhythmic activities 
of contraction and relaxation; this process is called vasomotion. These 
oscillations of arteriolar diameter, were described for the first time by Jones in 
1852 after his studies on the bat wing circulation [50]. Colantuoni et al. 
showed, in hamster, that the amplitude of these oscillations is strictly related to 
arteriolar size. In particular, smooth muscle cells of larger arterioles (with a 
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diameter between 50-100 μm) contract and dilate with a rate of 2-3 cycles per 
minute (cpm) with changes in diameter by 10-20 % of  baseline values. In 
smaller vessels this oscillatory activity became faster, so that in terminal 
arterioles  (diameter: <15 μm) the frequency is around 6-12 cpm and the 
maximal amplitude can reach the 100% of baseline diameter [51]. Moreover, 
this activity does not appear synchronized throughout the microvasculature. It 
is well known that vasomotion is associated to slow oscillations of smooth 
muscle membrane potential and of intracellular Ca2+ concentration. Therefore, 
these cyclic diameter variations are induced by synchronous calcium 
oscillations in smooth muscle cells, achieved by gap junctions. These, indeed, 
allow the passage of a depolarizing current leading to the simultaneous  
opening of voltage-dependent Ca2+ channels (VDCCs) and the diffusion of 
calcium ions between neighboring cells. The role of gap junction in smooth 
muscle cells sincronization has been investigated by the use of gap junction 
blockers demonstrating that interruption of gap junction desynchronizes Ca2+ 
transients and membrane potential oscillations without affecting Ca2+ waves. 
Therefore, this Ca2+ influx, synchronized through cells, activates Cl- and K+ 
conductance modulating vasomotion, as demonstrated in rat mesenteric artery 
[52-56]. The vasomotion can be observed only in vitro or in vivo by intravital 
microscopy.  
Many in vitro and in vivo studies showed that endothelium activity 
significantly influence vasomotion because NO and cGMP have a permissive 
role for smooth muscle cells synchronization [57,58]. It was shown that, in 
isolated rat arteries, the deprivation of endothelium abolished vasomotion. 
Ursino et al., indeed, demonstrated that Ach decreases vasomotion frequency 
and increases vasomotion amplitude and arteriolar diameter, while L-NMMA 
causes a slight increase in vasomotion frequency and decrease in effective 
diameter [59]. Moreover, the endothelium-derived hyperpolarizing factor 
(EDHF) release is involved in this mechanism and the sympathetic nerve 
activity has also an important role in the regulation of vasomotion, 
synchronizing the activity troughout the microvascular bed [60]. 
Many pathological conditions affect vasomotion, such as diabetes and 
hypertension [85-63]. 
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Therefore, the vasomotion is mainly due to the intrinsic myogenic 
activity of smooth muscle cells, but is influenced by many local and systemic 
regulatory mechanisms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5.: Cyclic variations of hamster subcutaneous arterioles;  
1 sec; b) 7 sec; c) 14 sec [51]. 
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1.2.3 The myogenic intrinsic activity 
 
Smooth muscle cells are able to respond to changes in mechanical load 
or intravascular pressure. An elevation of transmural pressure, indeed, induces 
vasoconstriction, while pressure reduction induces vasodilation. The intrinsic 
activity of smooth muscle cells is foundamental to maintain vascular 
resistance, protecting smaller arterioles and capillaries from damage during 
perfusion changes [64]. This myogenic response is not related to endothelium 
or sympathetic activities, as demonstrated by many in vitro models.  
In 1969 Uchida and Bohr showed for the first time that Ca2+ supply is 
fundamental for the maintenance of arteriolar tone [65]. Further studies 
demonstrated that many classes of ion channels present in vascular smooth 
muscle, exhibit stretch sensitivity. In particular, changes in pressure induce 
Ca2+ entry through voltage-gated Ca2+ channels (VGCCs) contributing to 
contraction through Ca2+/calmodulin-induced activation of myosin light chain 
kinase. Therefore, gap junctions facilitate the transmission of myogenic 
response from the site of origin [66-69]. 
However, the release of vasoactive factors from endothelium and 
perivascular nerves as well as local metabolites can increase or decrease the 
level of myogenic tone and thus affect vascular resistance.  
In particular, vasoactive intestinal peptide (VIP), calcitonin gene-related 
peptide (CGRP) and atrial natriuretic peptide (ANP) induce smooth muscle 
cells relaxation, while norepinephrine, noradrenaline, angiotensin II, 
vasopressin and neuropeptide Y (NPY) determine the contraction. Moreover, 
many metabolites regulate local blood flow, such as interstitial PO2, PCO2 and 
Ph, lactic acid, ATP and ADP levels.  These chemical changes in interstitial 
fluid act directly on vascular smooth muscle cells through second messenger 
systems influencing the vasomotion. In particular, the reduction in PO2 or the 
increase in PCO2 induce, usually, vasodilation [70]. 
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1.2.4 Neural control mechanisms 
 
The sympathetic nervous significantly contribute to the regulation of 
blood flow. All arteries and arterioles, indeed, are well innervated by a 
complex network of noradrenergic nerve fibers producing vasoconstriction 
after α1 receptors activation. Bigger arterioles show, usually, significant 
changes in diameter remaining constricted throughout the 1 min stimulation 
period. On the other hand, venules and veins show no response to sympathetic 
stimulation [71]. 
 
 
         1.2.5 The endothelium and its role in regulating blood flow 
 
Nitric oxide.  
Nitric oxide release from endothelial cells represents one of the most 
important vasodilatory mechanisms regulating local blood flow. Nitric oxide 
(NO) diffuses from endothelial cells inducing smooth muscle cells release 
through the activation of soluble guanylate cyclase. This dimeric protein has 
two subunits containing the heme group and is able to bind NO forming a Fe-
NO complex. The formation of this complex activates the enzyme, leading to 
GMPc accumulation. This second messenger stimulates protein kinase G 
(PKG) and GMPc-dependent ion channels, inducing muscle relaxation (Fig. 
1.6). 
Endothelial nitric oxide synthase (eNOS) is activated by several 
agonists, interacting with membrane receptors coupled to protein G, or by 
physical stimuli such as shear stress. eNOS, through basal NO production, is 
the key enzyme in regulating vascular tone. It is also implicated in 
angiogenesis, remodeling and leukocytes or platelets adhesion. Its activity is 
finely regulated by multiple mechanisms involving both protein-protein 
interactions and post-translational changes of the enzyme itself. The interaction 
with calmodulin is necessary for the enzymatic activity of eNOS; moreover, 
eNOS activity is also closely related to intracellular calcium (Ca2+) 
concentration [72-73]. 
 
 19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.6.: e-NOS molecular structure [73]. 
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Endothelial derived hyperpolarizing factor (EDHF). 
An additional endothelium-dependent pathway inducing smooth muscle 
cells relaxation is called endothelium-derived.  
This non-characterized endothelial factor has been associated with the 
hyperpolarization of the vascular smooth muscle cells by SKCa and IKCa 
channels. Their activation leads to smooth muscle cells hyperpolarization 
directly by gap junctions or by K efflux from the intracellular compartment 
toward the extracellular space.  
 
Prostacyclin. 
Prostacyclin is the major metabolite of arachidonic acid produced by 
cyclooxygenase in endothelial cells. It activates IP receptors on vascular 
smooth muscle and, in most physiological arteries, produces relaxation. 
Depending on the artery and/or the species, a hyperpolarization can occur, 
which involves the opening of one or more of types of potassium channels. 
 
Endothelins. 
Endothelial cells produce different types of endothelins, molecules with 
many biological effects, including vasoconstriction. The 21-amino acid peptide 
endothelin-1 (ET-1) is the predominant isoform of the endothelin peptide 
family.  
ET-1 production is activated by different acute and chronic diseases 
such as hypertension, atherosclerosis and heart failure.   
 
Tromboxane A2. 
Tromboxane A2 is produced by arachidonic acid metabolism. Its 
activation in endothelial cells increases superoxide anion radical O2 levels 
inducing a significant reduction of NO bioavailability [71]. 
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1.2.6 The study of microcirculation:  
 from intravital microscopy to laser Doppler flowmetry. 
 
The study of vasomotion is possible only in vivo by intravital 
microscopy [74]. In particular, the creation of a cranial window to study the 
pial microcirculation represents a widely used experimental technique. The 
first approach, described in larger animals by Forbes in 1928, was based on an 
open skull window technique [75]; subsequently, Rosenblum, Zweifach and 
Wahl were able to observe pial microcirculation in mouse and rat [76-77]. 
However, the open window preparation presented many disadvantages, 
including the alteration of cerebrospinal fluid composition and the risk of brain 
herniation, especially during conditions such as hypoxia; all these factors 
significantly affected the microvascular analysis [78]. Therefore, in 1986, 
Morii et al. developed a closed cranial window technique to study the reactivity 
of rat pial arterioles and venules to adenosine and carbon dioxidein. This 
approach is now still used; the window (4 mm x 5 mm) is usually implanted 
above the left frontoparietal cortex so that the skull is exposed and the 
craniotomy is performed to remove the dura mater and to put in position a 
quarz microscope coverglass [79]. By fluorescent tracers, intravenously 
injected, it is possible to visualize vessels and characterize arteriolar tree, 
according to diameter, length and branchings. Lapi et al., indeed, characterized 
the geometric distribution of rat pial vessels demonstrating that arterioles 
respond in a size-dependent manner to acute stimuli such as hypoperfusion-
reperfusion injury [80].  
On the other hand, the direct study of arteriolar diameter changes is not 
possible in humans. However, the study of cyclic variations of blood flow in 
vessels, the flowmotion, allow us to receive informations about many 
physiological mechanisms influencing the microcirculation, such as the activity 
of smooth muscle cells [81,82]. The analysis of flowmotion can be assessed by 
laser Doppler flowmetry (LDF), a non-invasive technique useful in evaluating 
blood flow distribution to tissues. Tissue perfusion, indeed, is recorded by the 
application of a probe emitting a low-power monochromatic laser light on the 
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skin. The perfusion estimated by this technique is based on the assessment of 
the Doppler shift, which is scattered by moving red blood cells. The frequency 
and amplitude of the doppler effect are directly related to the number and 
velocity of red blood cells, not to their direction [83]. Many studies 
demonstrated the relationship between LDF and fluorescence flowmetry, 
venous occlusion plethysmography and heat thermal clearance [84]. Moreover, 
clinical applications of LDF have been previously demonstrated [85-89]. 
 
 
1.2.7 Spectral analysis of laser Doppler Flowmetry 
 
The oscillations of microvascular blood flow can be divided into 
different components by spectral analysis [90]. The Wavelet analysis proposed 
by Morlet (1983) is a scale-independent method comprising an adjustable 
window length [91]. Stefanovska et al. demonstrated that skin blood flow 
oscillations, recorded by laser Doppler flowmetry, can be analyzed by the 
Wavelet transform to receive informations about the influence of several 
physiological factors, involved in the regulation of blood flow: the NO-
independent and NO-dependent endothelial activities, the sympathetic nervous 
system discharge, the intrinsic myogenic activity of vascular smooth muscle 
cells, the respiration and the heart rate [92, 95].  
After spectral analysis of laser Doppler flowmetry, indeed, is possible 
to detect six characteristic frequency peaks within the interval 0.005–2 Hz. In 
this range, lower oscillations, between 0.005-0.0095 and 0.0095-0.21 Hz, have 
been related to NO independent and dependent endothelial cell activity. 
Moreover, the oscillations included in the range 0.021-0.052 Hz and 0.052–
0.145 Hz are related with the discharge of sympathetic nervous system 
(neurogenic activity) and the activity of the smooth muscle cells (intrinsic 
myogenic activity), respectively. On the other hand, higher frequency 
components, included in the ranges 0.145–0.6 and 0.6–1.6 Hz, are associated to 
central regulatory mechanisms, such as the respiration and the heart beat, 
respectively (Fig.1.7.) [93-98]. 
Therefore, spectral analysis of LDF allow us to study the influence of  
local and central mechanisms regulating skin blood flow distribution. 
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Fig. 1.7: (a) A typical laser Doppler flowmetry tracing  recorded from the volar 
side of the forearm during unstimulated blood flow (top), during iontophoresis 
with acetylcholine (ACh) (middle) and sodium nitroprusside (SNP) (bottom). 
(b) The spectrum of the laser Doppler blood flow signal in the six frequency 
intervals during unstimulated blood perfusion (top), during iontophoresis with 
ACh (middle) and SNP (bottom). The vertical lines indicate the outer limits of 
each frequency interval. (c) The wavelet transform of a 45-s time series section 
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of the Laser-Doppler blood flow signal during SNP iontophoresis. In the three-
dimensional plane the spectrum of the section is presented as the function of 
time and frequency and expressed in AU [95]. 
 
1.3 Obesity and microvascular dysfunction 
 
The prevalence of obesity is progressively increasing worldwide [99]. 
In particular, recent data indicate that 35,3% of Italian’s adult population is 
overweight, while 9,8% is obese. The regions of the South show higher 
percentage of obese individuals reaching values around 39% in Campania 
[100]. 
Obesity is defined as a condition when body mass index (BMI) is 
greater than 30 kg/m2 and results from the interaction between genetic 
predisposition, wrong food habits and sedentary lifestyle. However, many 
studies showed that abdominal obesity represents an important predictor of 
metabolic and cardiovascular diseases independently of BMI. Visceral fat, 
indeed, is not an inert tissue, but a functional endocrine organ. It produces 
several cytokines, such as tumor necrosis factor-α (TNF-α) and IL-6, inducing 
a chronic low-grade inflammatory state leading to the development of diabetes, 
hypertension and hyperlipidemia [101,102]. Abdominal fat reduction 
represents the first therapeutic approach in obese patients and even a moderate 
weight loss decreases abdominal fat and lipid content, reducing insulin 
resistance risk [103].  
It is well known that obesity is strictly associated to structural and 
functional changes of microcirculation contributing to organ damages and 
insulin resistence [104]. In particular, arteriolar tone appears affected in obese 
subjects and endothelial response to vasodilator factors, such as acetylcholine, 
blunted. Moreover, the capillary recruitment to reactive hyperemia and shear 
stress appears significantly reduced [105-108]. Clerk et al. demonstrated an 
impaired muscle microvascular effect of insulin in obese subjects [109]. 
Moreover, the skeletal muscle microcirculation of obese individuals is 
characterized by a decreased capillary density, a phenomenon called 
rarefaction [110], and vascular remodeling [111].  
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Therefore, obesity represents the primary cause of microvascular 
dysfunction, resulting in changes in tissue perfusion. 
             
1.3.1 Hyperlipidemia and microvascular dysfunction  
 
It is well known that hyperlipidemia is one of the main risk factors 
associated to atherosclerosis leading to the alteration of structure and function 
of the arterial wall, according with the inflammatory response [112]. 
Interestingly, many studies indicate that hyperlipidemia induces microvascular 
alterations long before the appearance of fatty streak lesions in large arteries. 
These microvascular changes have been demonstrated in animals fed a 
cholesterol-rich diet for two weeks [113,114]. Hyperlipidemic animals, indeed, 
showed a typical inflammatory phenotype in microvessels, characterized by an 
increased leukocytes and platelets adhesion to vessel walls and an enhanced 
oxygen radical production [114,115].  In particular, previous studies indicate 
that hypercholesterolemia reduces the ability of arteriolar endothelial cells to 
produce bioactive NO and directly affects vascular smooth muscle cell function 
increasing coronary arteriolar contractibility in response to norepinephrine 
[113,116,117]. All these mechanisms influence arteriolar structure and 
function, affecting smooth muscle tone and tissue perfusion.   
Moreover, hyperlipidemia causes stasis and aggregation of erythrocytes 
in capillaries as well as a reduced deformability of red blood cells [118,119].  
Granger demonstrated that, in experimental models, hyperlipidemia 
exacerbates the capillary response to ischemia-reperfusion injury significantly 
increasing microvascular permeability, compared to controls [120]. An 
enhanced expression of P-selectin, ICAM-1, and VCAM-1 is evident on 
venular walls of hypercholesterolemic animals, consequently inducing 
leukocyte rolling, adhesion and migration through vascular wall. All these 
mechanisms increase radical oxygen production, decreasing NO bioavailability 
in microvascular endothelium [121]. 
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Chapter 2 
 
Aim 
 
Epidemiological studies clearly demonstrate that Mediterranean diet is 
a healthy eating plan associated with a reduction of acute and chronic diseases 
[1-4,16-18]. Many Authors focused the attention on the beneficial properties of 
extravirgin olive oil, the main source of fats in the Mediterranean Diet, because 
of its high amount in monounsaturated fatty acids, vitamins and polyphenols. 
Consequently, the effects of polyphenol rich olive oil on health have been well 
studied in clinical trials, demonstrating several improvement in endothelial 
function, inflammation levels and lipid profile [31,32]. 
However, the effects of oleuropein on microvascular function have not 
been fully clarified. In vivo studies have shown that this molecule is able to 
reduce LDL oxidation and plasma cholesterol levels in rabbits [41]. In 
addition, Manna et al. showed that oleuropein protects isolated rat hearts from 
oxidative damage induced by ischemia-repefusion injury [42]. This polyphenol 
appears able to reduce VCAM-1 expression on endothelial wall, leukocyte 
adhesion and metalloprotease 9 expression [47]. Oleuropein’s antioxidant, anti-
inflammatory and antiaterogenic properties indicate that this molecule may 
protect microcirculation by acute damage, such as hypoperfusion-reperfusion 
injury. Therefore, the first aim of the present study was to evaluate the in vivo 
protective effects of oleuropein on rat pial microvascular responses induced by 
30 min hypoperfusion and 60 min reperfusion. Rat pial microcirculation was 
visualized by fluorescence microscopy technique. The hypoperfusion was 
induced by transient bilateral common carotid arteries occlusion. Subsequently, 
after arterial occlusion removal, the microcirculation was observed for 60 
minutes (reperfusion period).  
We studied oleuropein effects on microvascular parameters, such as 
arteriolar diameter changes, microvascular permeability increase, leukocyte 
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adhesion to vessel walls and capillary perfusion. We chose to evaluate pial 
arteriolar changes because these vessels constitute a complex network 
characterized by at least five orders of vessels, regulating blood flow to the 
surrounding cerebral tissue [80].  
The working hypothesis was that this polyphenol could induce 
vasodilation through the NO release, as previously described [122] and 
consequently protect cerebral blood flow distribution and cerebral tissue. 
Therefore, we studied the effects of inhibiting endothelial nitric oxide synthase 
(eNOS) by N(5)-(1-iminoethyl)-L-ornithine (L-NIO), prior to oleuropein 
administration, on microvascular responses. Moreover, rat cerebral cortical and 
striatum eNOS protein levels were evaluated; finally, oxidative stress induced 
by hypoperfusion and reperfusion on brain tissue was quantified utilizing 2’-7’-
dichlorofluorescein-diacetate test (DCFH-DA). 
The second part of the study was focused on the oleuropein effects on 
skin blood flow oscillations of hyperlipidemic obese females administered with 
a hypocaloric and hypolipidic diet. We hypothesized that skin microvascular 
function can mirror the state of microcirculation in other microvascular beds, 
as previously demonstrated [123,124]. Hypercholesterolemic patients, affected 
by coronary artery disease, are characterized by a blunted skin vasodilator 
response to Ach. Moreover, Rossi et al. showed that hypercholesterolemic 
patients without clinically manifest arterial diseases showed early sign of skin 
endothelial dysfunction, detected by laser Doppler flowmetry [125].  
Therefore, we investigated skin microvascular blood flow impairments 
in newly diagnosed hyperlipidemic obese subjects using noninvasive LDF 
technique. Skin microvascular blood flow (SBF) was evaluated under resting 
conditions in all recruited patients. Moreover, to assess the peripheral 
microvascular reactivity, we detected the post-occlusive reactive hyperemia 
(PORH). Oscillations in blood flow were analyzed by spectral analysis of 
LDPM signals to study the influence of central and local regulatory 
mechanisms on skin blood flow distribution [95-97]. Finally, the effects of an 
oleuropein rich diet, administered for 3 months, were investigated. These data 
were compared with those detected in hyperlipidemic obese patients 
administered with hypocaloric and hypolipidic diet. Under baseline conditions, 
 28 
 
hyperlipidemic obese subjects were compared with an age-matched group of 
normolipidemic obese people and an age-matched group of normal weight 
individuals.     
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Chapter 3 
Matherials and Methods 
 
 
3.1. In vivo experimental study 
3.1.1. Experimental Groups 
 
All experiments are conform to the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH Publication 
No. 85–23, revised 1996) and to institutional rules for the care and handling of 
experimental animals. The protocol was approved by the “Federico II” 
University of Naples Ethical Committee. 
Male Wistar rats, 250–300 g b.w. (Harlan, Italy), were used and randomly 
assigned to four groups.  
1. The first group included animals not subjected to BCCAO and reperfusion 
[Sham Operated group, n = 14]. Five animals received 1.5 mL 
physiological saline solution i.v. injected (S subgroup, n = 5). Moreover, S 
rats received i.v. oleuropein 10 or 20 mg/kg b.w. (S/OL1 and S/OL2 
subgroups; n = 3, respectively) or i.v. L-NIO 10 mg/kg b.w. (S/L subgroup, 
n = 3). 
2. Hypoperfused rats (I group, n = 19) were treated with 1.5 mL vehicle i.v. 
injected (physiological saline solution) and subjected to 30 minutes of 
BCCAO and 60 minutes of reperfusion. 
3. OL group (OL1 subgroup, n =5; OL2 subgroup, n = 19) was administered 
with i.v. oleuropein, 10 or 20 mg/kg b.w., respectively, 10 minutes prior to 
BCCAO and at the beginning of reperfusion. 
4. The fourth group of animals (L/OL group, n = 19) was administered with 
i.v. L-NIO (10 mg/kg b.w.) prior to i.v. oleuropein (20 mg/kg b.w.), 10 
minutes before BCCAO and at the beginning of reperfusion.  
For all groups, five animals were used for microvascular observations; 
five animals were utilized to evaluate the eNOS expression by western blotting. 
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Three animals were used to determine neuronal damage by 2,3,5- 
triphenyltetrazolium chloride staining and six animals were submitted to 
DCFH-DA assay after I (n = 3) or after reperfusion (n = 3). Animals belonging 
to OL1 subgroup were exclusively utilized for microvascular studies.  
 
3.1.2. Administration of Drugs 
Oleuropein solution was obtained dissolving 10 or 20 mg/kg b.w. in 0.5 
mL saline solution and i.v. infused (three minutes) into the rats 10 minutes 
before BCCAO and at the beginning of reperfusion, as previously described 
[122]. L-NIO (10 mg/kg b.w) was dissolved in 0.5 mL saline solution and i.v. 
administered prior to oleuropein (20 mg/kg b.w.) according to the protocol 
time schedule reported in Figure 3.1. In preliminary experiments L-NIO 
infusion at the dosage of 10 mg/kg b.w. chosen for the present study, abolished 
vasodilation due to topical application of acetylcholine, 100 µM (n = 10), 
where the diameter increase was by 23.8 ± 2.5% of baseline under control 
conditions (n = 10). DCFH-DA was mixed with aCSF to obtain a concentration 
of 250 mM [129]. This solution was superfused over the pial surface for 15 
minutes during BCCAO or reperfusion. The drugs were purchased from Sigma 
Chemical, St. Louis, MO, USA.  
 
3.1.3. Animal Preparation 
Anesthesia was induced with a-chloralose (50 mg/kg b.w. 
intraperitoneal injection) and maintained with 30 mg/kg/h intraperitoneal 
injection. Rats were tracheotomized, paralyzed with tubocurarine chloride (1 
mg/kg/h, i.v.), and mechanically ventilated with room air and supplemental 
oxygen. The right and left common carotid arteries were isolated for successive 
clamping. A catheter was placed in the left femoral artery for arterial blood 
pressure recording and blood gases sampling. Another one in the right femoral 
vein for injection of the fluorescent tracers and drugs. FITC, 50 mg/100 g b.w., 
i.v. as 5% wt/vol solution in three minutes administered just once at the 
beginning of experiment after 30 minutes of the preparation stabilization; 
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rhodamine 6G,1 mg/100 g b.w. in 0.3 mL, as a bolus with supplemental 
injection throughout BCCAO and reperfusion (final volume0.3 mL/100 g/h) to 
label leukocytes for adhesion evaluation, were the tracers. Blood gas 
measurements were carried out on arterial blood samples withdrawn from 
arterial catheter at 30 minutes time period intervals (ABL5; Radiometer, 
Copenhagen, Denmark). Throughout all experiments, MABP, heart rate, 
respiratory CO2, and blood gases values were recorded and maintained stable 
within physiological ranges. Rectal temperature was monitored and preserved 
at 37.0±0.5°C with a heating stereotaxic frame where the rats were secured. To 
observe the pial microcirculation, a closed cranial window (4 mm x 5 mm) was 
implanted above the left frontoparietal cortex (posterior 1.5 mm to bregma; 
lateral, 3 mm to the midline), as previously reported [126]. Briefly, the dura 
mater was gently removed and a 150-µm-thick quartz microscope cover glass 
was sealed to the bone with dental cement. The window inflow and outflow 
were assured by two needles secured in the dental cement of the windows o 
that the brain parenchyma was continuously superfused with aCSF [79,127]. 
The rate of superfusion was 0.5 mL/min controlled by a peristaltic pump. 
During superfusion the intracranial pressure was maintained at 5±1 mmHg and 
measured by a Pressure Transducer connected to a computer. The composition 
of the aCSF was: 119.0 mM NaCl, 2.5 mM KCl, 1.3 mM MgSO4, 1.0 mM 
NaH2PO4, 26.2 mM NaHCO3, 2.5 mM CaCl2, and 11.0 mM glucose 
(equilibrated with 10.0% O2, 6.0% CO2, and 84.0% N2; pH 7.38 ± 0.02). The 
temperature was maintained at 37.0 ± 0.5°C. The reduction of cerebral blood 
flow was produced by the placement of two atraumatic microvascular clips for 
30 minutes on common carotid arteries, previously isolated. After removing the 
clamp, the pial microcirculation was observed for 60 minutes (reperfusion 
period). 
 
3.1.4.Intravital Microscopy and Microvascular Parameter   
Evaluation  
Observations of pial vessels were conducted by a fluorescence 
microscope (Leitz Orthoplan, Wetzlar, Germany) fitted with long-distance 
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objectives [2.5X, NA 0.08; 10X, NA 0.20; 20X, NA 0.25; 32X, NA 0.40], a 10 
X eye piece and a filter block (Ploemopak; Leitz) as previously described 
[126]. Epiillumination was provided by a 100 W mercury lamp using the 
appropriate filters for FITC, for rhodamine 6G, and a heat filter (Leitz KG1). 
The pial microcirculation was televised with a DAGE MTI 300RC low-light 
level digital camera and recorded by a computer-based frame grabber (Pinnacle 
DC10 plus; Avid Technology, Burlingtton, MA, USA). Microvascular 
measurements were made off-line using a computer-assisted imaging software 
system (MIP Image, CNR, Institute of Clinical Physiology, Pisa, Italy). The 
visualization of pial microcirculation was carried out according to the protocol 
time schedule reported in Figure 3.1.  
 
 
 
 
 
 
 
 
 
Fig.3.1.: Experimental design of drug administration and measurement times. 
R: recording points. FITC: fluorescent-dextran (70kDa) and rhodamine 6G. 
So/I: solvent, 0.9% NaCl, and/or inhibitor administration (L-NIO). So/OL: 
solvent, 0.9% NaCl, and/or oleuropein administration. BCCAO: bilateral 
common carotid artery occlusion. Rhodamine 6G was injected after FITC 
dextran as a bolus and then infused during BCCAO and reperfusion. 
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Briefly, recording of microvascular images was performed for one 
minute every five minutes during substance administration, before BCCAO 
and at the beginning of reperfusion. Afterward, recording was carried out every 
10 minutes during BCCAO and the remaining reperfusion. The baseline 
conditions were represented by microvascular values detected within two 
minutes of FITC administration. The pial arteriole responses to the different 
substances were homogeneous during BCCAO and reperfusion; therefore, we 
chose to present data recorded under the baseline conditions, at the end of 
BCCAO and RE. Under baseline conditions, the arteriolar network was 
mapped by stop-frame images and pial arterioles were classified according to a 
centripetal ordering scheme (Strahler’s method, modified according to 
diameter), as previously described [126]. In each animal, one order 4, two 
order 3 and two order 2 arterioles were studied during each experiment. 
Because of the homogeneous responses, we chose to present only the data 
regarding order 3 vessels. Arteriolar diameters were measured with a 
computer-assisted method (MIP Image program, frame by frame). The results 
of diameter measurements were in accord with those obtained by shearing 
method (±0.5 µm). To avoid bias due to single operator measurements, two 
independent “blinded” operators measured the vessel diameters. Their 
measurements overlapped in all cases. The increase in leakage was calculated 
and reported as NGL: NGL = (I - Ir)/Ir, where Ir is the average baseline grey 
level at the end of vessel filling with fluorescence (average of five windows 
located outside the blood vessels with the same windows being used 
throughout the experimental procedure), and I is the same parameter at the end 
of BCCAO or RE. Grey levels ranging from 0 to 255 were determined by the 
MIP Image program in five ROI measuring 50 µm x 50 µm (10x objective). 
The same location of ROI during recordings along the microvascular networks 
was provided by a computer-assisted device for XY movement of the 
microscope table. Adherent leukocytes (i.e., cells on vessel walls that did not 
move over a 30-second observation period) were quantified in terms of 
number/100 µm of v.l./30 sec using higher magnification (20x and 32x, 
microscope objectives). In each experimental group 45 venules were studied. 
PCL was measured by MIP image in an area of 150 µm x 150 µm. In this 
system, the length of perfused capillaries is easily established by the automated 
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process because it is outlined by dextran. MABP (Viggo-Spectramed P10E2 
transducer, Oxnard, CA, USA – connected to a catheter in the femoral artery) 
and heart rate were monitored with a Gould Windograf recorder (model 13-
6615-10S, Gould, OH, USA), connected to a computer. Blood gas 
measurements were carried out on arterial blood samples with drawn from 
arterial catheter at 30 minutes time period intervals (ABL5; Radiometer, 
Copenhagen, Denmark). The hematocrit was measured under baseline 
conditions, at the end of BCCAO and at RE. Furthermore, microvascular blood 
flow was measured by LDPM on the skull of all animals using a Perimed 
PF5000 flowmeter with a probe (457; Perimed, Jarfalla, Sweden) attached to 
the bone. The sampling rate was 32 Hz and blood flow was expressed as PU. 
We chose to present only LDPM blood flow data of hypoperfused rats (I 
group) and oleuropein-treated animals (OL2 subgroup), to simplify data 
presentation. 
3.1.5. Western Blot Analysis 
Protein concentrations were determined by the Bio-Rad protein assay 
(Bio-Rad, Berkeley, CA, USA). Equal amounts of proteins were separated by 
SDS-PAGE under reducing conditions and then transferred to (PVDF; 
Invitrogen, Carlsbad, CA, USA). The immunoblot was blocked, incubated with 
specific antibodies at 4°C overnight, washed, and then incubated for one hour 
with horseradish peroxidase-conjugated secondary antibody (1:2000) (GE-
Healthcare, Little Chalfont, UK). Peroxidase activity was detected by enhanced 
chemiluminescence system (GE-Healthcare). The optical density of the bands 
was determined by the ChemiDoc Imaging System (Bio-Rad) and normalized 
to the optical density of a-Tubulin (1:5000). To detect the proteins of interest, 
specific antibodies were used: rabbit polyclonal anti-eNOS (1:500) and rabbit 
poly-clonal anti-phosphorylated eNOS (Ser1177) (1:200). Antibodies were 
purchased from Santa Cruz Biotecnology, SantaCruz, CA, USA. 
 
3.1.6. 2, 3, 5-triphenyltetrazolium Chloride Staining  
Rats were sacrificed after 30 minutes BCCAO and 60 minutes 
reperfusion. Tissue damage was evaluated by 2,3,5- TTC staining. The brains 
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were cut into 1 mm coronal slices with a vibratome (Campden Instrument, 752 
M). Sections were incubated in 2% TTC for 20 minutes at 37°C and in 10% 
formalin overnight. The necrotic area site and extent in each section were 
evaluated by image analysis software (Image-ProPlus, Rockville, MD, USA) 
[128].  
 
3.1.7. DCFH-DA Assay  
A CSF containing 250 mM DCFH-DA at 37.0 ± 0.5°C was superfused 
over the pial surface. The lipophilic DCFH-DA is a stable non fluorescent 
probe with a high cellular permeability. DCFH-DA reacts with intracellular 
radicals to be converted to its fluorescent product (DCF). The remaining 
extracellular DCFH-DA was washed out with aCSF. The intensity of DCF 
fluorescence is proportional to the intra-cellular ROS level. The fluorescence 
intensity was determined by the use of an appropriate filter (522 nm) and 
estimated by NGL, with the baseline represented by pial surface just 
superfused by DCFH-DA [129].  
 
3.1.8. Sample size and statistical power 
The sample size calculation was performed using MedCalc. The 
outcome for the calculation of sample size was the permeability increase at the 
end of reperfusion. A difference of 20% between hypoperfused and oleuropein-
treated group was estimated. Power and significance levels were set at 0.80 and 
0.05, respectively. Moreover, we considered a 25% of possible intraoperative 
death. Using these parameters we evaluated a sample size of 5 animals per 
group, for microvascular studies. 
 
3.1.9. Statistical Analysis 
All reported values are mean ± SEM. Data were tested for normal 
distribution with the Kolmogorov–Smirnov test. Parametric (Student’s t tests, 
ANOVA, and Bonferroni post hoc test) or nonparametric tests (Wilcoxon, 
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Mann–Whitney, and Kruskal–Wallis tests) were used. Nonparametric tests 
were applied to compare diameter and length data among experimental groups. 
Due to the small sample size of DCFH-DA treated rats we used nonparametric 
tests to compare the results obtained in these animals. The statistical analysis 
was carried out by SPSS 14.0 statistical package. Statistical significance was 
set at p < 0.05. 
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3.2.Clinical study 
 
3.2.1.Study design 
The study protocol was approved by the Ethical Committee of the Federico II 
University Medical School of Naples and all patients gave written informed 
consent.  
Under baseline conditions, forty hyperlipidemic obese subjects (HO group) 
were recruited from the Outpatient Clinic of the Department of Clinical 
Medicine and Surgery, “Federico II” University of Naples and compared with 
an age-matched group of normolipidemic obese people (O group) and an age-
matched group of normal weight individuals (NW group). After baseline 
evaluations, hyperlipidemic patients were randomized in two subgroups: OL 
subgroup was administered with a hypocaloric and hypolipidic diet plus 
oleuropein (90 mg/day), while OD subgroup was treated with the hypocaloric 
and hypolipidic diet; the treatment lasted 12 weeks (Fig.3.2). 
All patients were 55–64 years old sedentary women; those belonging to 
HO, divided in two subgroups, OD and OL, were hyperlipidemic and obese 
[body mass index (BMI) ≥ 30 Kg/m2; total cholesterol> 200 mg/dL, LDL 
cholesterol>130 mg/dL, triglycerides >150 mg/dL]. Patients belonging to O 
group were normolipidemic obese (BMI≥ 30 Kg/m2) while those of NW group 
were normalweight (BMI between 19 – 25 Kg/m2).  
Exclusion criteria were: presence of diseases influencing body 
composition (cancer, osteoporosis and muscular dystrophia), heart failure and 
microangiopathy; weight loss medications (sibutramine, orlistat, rimonabant) 
and history of bariatric surgery; subjects on hormonal therapies (oestrogens, 
thyroxine, progesteron), anti-hypertensive therapies (Ca++ channel blockers, 
ACE inhibitors), statins and any other antidyslipidemic agent or psychiatric 
drugs ; treatment with drugs influencing microvascular blood flow (such as 
vasodilators and anti-inflammatory drugs) and smokers. 
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Fig.3.2.:  Clinical study design. NW= normal weight group; O= obese group; 
HO= hyperlipidemic obese group; OD= hyperlipidemic obese females administered with 
hypocaloric and hypolipidic diet; OL= hyperlipidemic obese females administered with 
hypocaloric and hypolipidic diet plus oleuropein. 
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3.2.2. Study Protocol 
Under baseline conditions and after three months of hypocaloric and 
hypolipidic diet, nutritional status, skin microvascular blood flow, 
microvascular blood flow oscillations and hyperemic response were 
investigated in all hyperlipidemic patients. 
In particular, nutritional status was evaluated by anthropometric 
measurements, such as weight, height, body mass index (BMI), waist 
circumference (WC), hip circumference (HC) and triceps skinfold (TS). 
Bioimpedance analysis (Akern RJL, BIA 101) was carried out to evaluate the 
hydration as well as the Fat Mass (FM). Total serum cholesterol, HDL 
cholesterol, LDL cholesterol, triglycerides, GOT and GPT were measured.  
Microvascular blood flow evaluation was performed on patients in 
supine position in a quiet and temperature-controlled room (22 ± 3 °C). No 
subjects had any medication, food, alcohol and/or drinks containing caffeine 12 
h prior to the blood flow measurement. SBF was recorded using a laser 
Doppler perfusion monitoring apparatus (PeriFlux 5001 System, Perimed, 
Stockholm, Sweden). The laser Doppler probe (PF 457, Perimed, Stockholm, 
Sweden), connected to a computer, was placed on the right forearm volar 
surface. After 10 min of acclimatization, the blood flow was recorded for 20 
min by a Perisoft software. The mean skin blood perfusion was expressed as 
arbitrary perfusion units (PU), while the power spectral density (PSD) of laser 
Doppler signals was reported as PU2/Hz. Finally, skin blood flow oscillations 
were analyzed by the Wavelet transform [95]. 
Post-occlusive reactive hyperemia was evaluated in all patients under 
baseline conditions and after three months treatment. The brachial artery was 
occluded by a blood pressure cuff, placed at the right upper arm and inflated up 
to 50 mmHg above the systolic blood pressure. The blood pressure cuff was 
suddenly deflated after 3 min brachial artery occlusion. The peak value (PK), 
expressed as PU, was determined calculating the maximal perfusion value 
reached during reactive hyperemia; the percent increase in flow during 
hyperemic response (PK%) was calculated from the basal mean value; the time 
to peak (Tp) was measured in seconds as the time from cuff release to the 
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maximum peak value; the duration of hyperemia was evaluated in seconds as 
the time from cuff release up to the recovery of the mean value. 
 
3.2.3.Spectral analysis 
Microvascular blood flow oscillations, in the range 0.005 to 2.0 Hz, 
were evaluated by the Wavelet transform, a scale dependent method 
comprising an adjustable window length able to analyze both low and high 
frequencies. Spectral analysis was performed on 20 min recordings under 
resting conditions, to obtain higher resolution of very low frequency 
components. Wavelet analysis, proposed by Morlet, permits to detect at least 
six frequency components in this interval, as reported by Stefanovska et al 
[95]. First, the overall spectral density of each frequency interval was 
determined; then the normalized spectral density for each frequency interval 
was evaluated as the ratio between the average spectral density of a specific 
frequency interval and the average total power spectral density. Therefore, the 
relative contribution of each frequency component was defined for the entire 
spectrum. 
 
3.2.4. Diet composition 
A Mediterranean diet, low in calories (25 kcal/kg ideal body weight) 
and fats, was recommended to all obese patients. The eating plan was 
characterized by 50-55 % of total caloric intake from carbohydrates, 15-20 % 
from proteins, 25% from fatty acids (< 7% saturated fats) and 30 grams of fiber 
per day. The daily cholesterol intake was less than 200 mg, according to the 
Italian guidelines suggestions [130].  
 
3.2.5. Oleuropein supplementation 
Partecipants belonging to OL group were instructed to take one 
capsule/day containing 90 mg oleuropein (LongLife), orally ingested with 
water during dinner for three months. 
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3.2.6. Compliance 
 Compliance with the dietary intervention was assessed by monitoring 
the dietary intake at baseline and every month until the end of the study by  
Food Frequency Questionnaires [131]. 
Assessment of compliance with the physical activity was verified by 
asking subjects to complete a physical activity questionnaire [132]. 
Compliance with the oleuropein supplementation was evaluated by the 
completion of a daily questionnaire asking each volunteer about the time of the 
consumption of the supplement as well as evaluating the presence of adverse 
events. 
 
3.2.7. Sample size and statistical power 
The sample size calculation was performed using MedCalc. The 
outcome for the calculation of sample size was the increase in skin blood 
perfusion levels in oleuropein treated group. A difference of 20% between 
intervention and control was estimated. Power and significance levels were set 
at 0.80 and 0.05, respectively. Using these parameters the estimated sample 
size was of 20 participants per group. 
 
3.2.8. Statistical analysis 
All data were expressed as mean ± standard error of the mean (SEM). 
Data were tested for normal distribution with the Kolmogorov-Smirnov test. 
Parametric (Student’s t tests, ANOVA and Bonferroni post hoc test) or 
nonparametric tests (Wilcoxon, Mann-Whitney and Kruskal-Wallis tests) were 
used. The statistical analysis was carried out by SPSS 14.0 statistical package. 
Statistical significance was set at p<0.05. 
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Chapter 4 
Results 
 
4.1.The in vivo study 
Under baseline conditions pial arterioles were classified in five orders 
according to diameter, length and branching, as previously described [80]. 
Capillaries were assigned order 0, the smallest arterioles order 1 (average 
diameter: 15.7±2.0 µm and average length: 152 ± 74 µm; n = 150), while the 
largest ones order 5 (average diameter: 58.5 ± 4.2 µm and length of 1184 ± 330 
µm (n = 92). The values of diameters and lengths were significantly different 
among the different arteriolar orders (p < 0.01) [80].  
 
4.1.2. Sham-Operated Animals 
S animals did not show changes in arteriolar diameter nor increase in 
leakage nor adhesion of leukocytes nor decrease in capillary perfusion during 
the same period of observation as in the other experimental groups (Table 4.1, 
Figure 4.1). The S animals treated with oleuropein (at the doses of 10 or 20 
mg/kg b.w.) showed a dose-related dilation of all arterioles in both subgroups. 
In particular, order 3 arterioles dilated by 10±2% of baseline at the higher 
dosage of oleuropein (S/OL2 subgroup) (p < 0.01 vs. baseline). We did not 
observe significant changes in the other parameters when compared with 
baseline. L-NIO did not significantly affect diameter of vessels nor the other 
parameters (Table 4.1). 
 
4.1.3. Hypoperfused animals 
At the end of BCCAO, these animals (I group) showed a decrease in 
diameter of all arteriolar orders; in order 3 vessels the reduction was by 18.5 
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±2.0% of baseline (p < 0.01 vs. S subgroup and baseline) (Figure 4.1.). 
Microvascular leakage significantly increased compared with baseline 
(NGL:0.22 ± 0.04; p < 0.01 vs. S subgroup and baseline). We did not observe 
changes in venular diameter, while most capillaries were not perfused (Table 
4.1.1). At RE, the diameter of all arteriolar orders decreased (in order 3 by 13.2 
± 3.5% of baseline; p < 0.01 vs. S subgroup and baseline) (Figure 4.1). 
Microvascular leakage significantly increased (NGL: 0.45 ±0.05; p < 0.01 vs. S 
subgroup and baseline) and leukocyte adhesion was markedly elevated (9 ± 
2/100 µm v.l./30 sec; p < 0.01 vs. S subgroup and baseline); PCL decreased by 
46 ± 4% of baseline (p < 0.01vs. S subgroup and baseline) (Table 4.1.1, Figure 
4.1.1. A, B). At the end of BCCAO, microvascular blood flow recorded by 
LDPM on the contralateral parietal skull was reduced by 65.0 ± 6.5% of 
baseline (p < 0.01 vs. S subgroup and baseline, 35.8 ± 4.0 PU). At reperfusion, 
after a transient increase (4 ± 2 minutes) in microvascular blood flow, there 
was a decrease of blood flow (by 30.5 ± 4.0% of baseline; p < 0.01 vs. S 
subgroup and baseline) up to the end of observations. 
 
4.1.3 Oleuropein effects on pial microcirculation 
Oleuropein (subgroups: OL1 and OL2) caused dose-related 
microvascular effects. At the end of BCCAO, the higher dose induced dilation 
in all arteriolar orders (by 7.5 ± 2.0% of baseline in order 3; p < 0.01 vs. I 
group); moreover, FD70 leakage was significantly prevented compared with 
hypoperfused animals (NGL: 0.11 ± 0.02; p < 0.01 vs. I group) (Table 4.1.1., 
Figure 4.1.). At RE all pial arterioles dilated: by 28 ±2% of baseline in order 3 
(p < 0.01 vs. I group) (Figure 4.1). Microvascular leakage was prevented 
(NGL: 0.13 ± 0.03; p < 0.01 vs. I group) as well as leukocyte adhesion (2.0 ± 
0.5/100 µm v.l./30 sec; p < 0.01 vs. I group), while capillary perfusion 
decreased by 26.0 ± 4.5% of baseline (p < 0.01 vs. I group) (Table 4.1.1., 
Figure 4.1.1. C, D). Oleuropein higher dosage increased microvascular blood 
flow by 20.4 ± 4.0% of baseline (p < 0.01 vs. baseline), as detected by LDPM 
on the contralateral parietal skull prior to BCCAO. At the end of BCCAO, 
there was a decrease of blood flow by 18 ± 7% of baseline (p < 0.01 vs. S 
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subgroup, baseline and I group). At RE blood flow increased by 28 ± 4% of 
baseline ( p < 0.01 vs. S subgroup, baseline and I group). 
 
4.1.4 eNOS Inhibition 
At the end of BCCAO, L-NIO prior to oleuropein (group L/OL) caused 
reduction in diameter of all arteriolar orders: by 5.5 ± 1.5% of baseline in order 
3 (p< 0.01 vs. I group and OL2 subgroup) (Figure 4.1). Microvascular leakage 
decreased compared with hypoperfused animals (0.15 ± 0.02 NGL; p < 0.01 vs. 
I group) (Table 4.1.1.). At RE, the diameter of all arterioles decreased (by 6.5 ± 
2.0% of baseline in order 3; p < 0.01 vs. I group and OL2 subgroup) (Figure 
4.1). The protective effect of oleuropein on microvascular leakage was 
attenuated (NGL:0.18 ± 0.03; p < 0.01, vs. I group), leukocytes adhesion to 
venules was reduced (5 ± 2/100 µm v.l./30 sec; p < 0.01, vs. I group), while 
PCL decreased by 32 ± 3% of baseline (p < 0.01 vs. I group) (Table 4.1.1). 
Finally, physiological parameters, such as hematocrit, MABP, heart rate, pH, 
PCO2 and PO2 did not change in the different experimental groups up to RE 
(data not shown).  
 
4.1.5 eNOS Expression 
Western blot analysis revealed that eNOS protein expression increased 
at RE in animals treated with oleuropein compared to I and S group. In all 
animals the eNOS protein concentration was the higher in cortex compared to 
striatum. Both total and phosphorylated eNOS proteins increased to the same 
extent (Figure 4.1.2). 
 
4.1.6. Tissue Damage Evaluation 
The neuroprotective effects of oleuropein were assessed by evaluating 
damaged area after 30 minutes BCCAO and 60 minutes reperfusion. In 
hypoperfused rats, TTC staining revealed a massive lesion of striatum in both 
hemispheres, while cortical and sub-cortical areas presented slight injury. The 
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higher dose of oleuropein were able to reduce neuronal damage, compared with 
that observed in hypoperfused animals (Fig.4.1.3).  
 
4.1.7 ROS Quantification 
DCFH-DA superfusion in sham operated rats did not cause significant 
increase in DCF fluorescence intensity at the end of observations (0.04 ± 0.02 
NGL). In hypoperfused animals DCFH-DA superfusion induced an increase in 
DCF fluorescence intensity at the end of BCCAO (0.23 ± 0.02 NGL, p < 0.01 
vs. S subgroup and baseline). The fluorescence was higher at RE (0.30 ± 0.03 
NGL, p < 0.01 vs. S subgroup and baseline) likely because of further increase 
in ROS production. Higher dose of oleuropein decreased DCF fluorescence 
intensity compared with hypoperfused animals: at the end of BCCAO, NGL 
were 0.09 ± 0.02 and 0.08 ± 0.01 (p < 0.01 vs. I group), respectively. At RE, 
NGL were 0.15 ± 0.03 and 0.13 ± 0.02 (p < 0.01 vs. I group), respectively. 
Administration of L-NIO prior to oleuropein did not significantly change the 
effects of oleuropein on ROS formation (Fig. 4.1.4.). 
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Table 4.1.: Variations of the main parameters in sham-operated 
subgroups: S/OL1 (oleuropein, 10 mg/kg b.w), S/OL2 (oleuropein, 20 mg/kg 
b.w.), S/L (L-NIO, 10 mg/kg b.w.), S (physiological saline solution, 1.5 mL). 
 
 
 
 
 
 
 
Sham-operated 
subgroups 
 
Number of 
animals (n) 
 
Microvascular 
leakage  (NGL) 
 
Leukocyte adhesion  
(Number of 
leukocyte/100µm of 
venular length/30s) 
 
Capillary 
perfusion 
(% reduction 
compared to 
baseline) 
S/OL1 3 0.04± 0.02 2.0 ± 0.4 0 ± 5 
S/OL2 3 0.02± 0.01 1.0 ± 0.5 0 ± 5 
S/L 3 0.03± 0.01 1.0 ± 0.2 0 ± 5 
S 5 0.04± 0.02 2.0 ± 0.3 0 ± 5 
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Table 4.1.1.: Variations of the main parameters in sham-operated (S) 
subgroup, hypoperfused (I) group, oleuropein (OL2) subgroup (20 mg/kg b.w.); 
L-NIO (10 mg/kg b.w) and oleuropein (20 mg/kg b.w.) (L/OL) group; 
°p<0.01 vs S group and baseline; *p < 0.01 vs. I group,  
 
 
 
 
 
 
Groups 
 
Number of 
animals (n) 
 
Microvascular 
leakage (NGL) 
 
Leukocyte adhesion  
(Number of 
leukocyte/100µm of 
venular length/30s) 
Capillary 
perfusion 
(% reduction 
compared to 
baseline) 
S 5 0.04± 0.02 2.0 ± 0.3 0 ± 5 
I 19 0.45 ± 0.05° 9 ± 2° 46 ± 4° 
OL2 19 0.13 ± 0.03°* 2.0 ± 0.5°* 26.0 ± 4.5°* 
L/OL 19 0.18 ± 0.03°*  5 ± 2°* 32 ± 3°* 
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Fig. 4.1.: Diameter changes in the experimental groups. Diameter 
changes of order three arterioles, expressed as percent of baseline at the end of 
BCCAO and reperfusion (RE) in S = sham operated subgroup; I = 
hypoperfused group; OL2= oleuropein subgroup (20 mg/kg b.w.); L/OL = L-
NIO (10 mg/kg b.w.) and oleuropein (20 mg/kg b.w.) group;  
°p < 0.01 vs. S subgroup and baseline, *p < 0.01 vs. I group, +p < 0.01 
vs. OL2 subgroup. 
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Fig.4.1.1.: Computer-assisted images of a pial microvascular network under 
baseline conditions (A) and RE (B) in one of the hypoperfused rats. The 
increase in microvascular leakage is outlined by the marked change in the color 
of interstitium (from black to white). Computer-assisted images of a pial 
microvascular network under baseline conditions (C) and RE in an oleuropein-
treated rat (20 mg/kg b.w.) (D);  
Scale bar = _____100 µm. 
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Fig. 4.1.2.: Western blotting of eNOS expression and phosphorilated 
eNOS expression in two cerebral zones, cortex and striatum, at RE in S = sham 
operated subgroup; I = hypoperfused group; OL2 = oleuropein subgroup (20 
mg/kg b.w.); L/OL = L-NIO (10 mg/kg b.w.) and oleuropein (20 mg/kg b.w.) 
group; °p < 0.01 vs. S subgroup and baseline, *p < 0.01 vs. I group, +p < 0.01 
vs. OL2 subgroup 
STRIATUM 
CORTEX 
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Fig. 4.1.3.: TTC staining of coronal brain slice from a rat submitted to 
BCCAO and reperfusion. The lesion in the striatum is outlined by the 
dashed black line (A). TTC staining of coronal brain slices from a rat 
treated with higher dose oleuropein (20 mg/kg b.w.) (B). 
 
A 
B 
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Fig. 4.1.4.: Changes in DCF fluorescence intensity correlated to the 
intracellular ROS levels at the end of BCCAO and reperfusion (RE) in the 
different experimental groups: S = sham operated subgroup; I = hypoperfused 
group; OL2= oleuropein subgroup (20 mg/kg b.w.); L/OL = L-NIO (10 mg/kg 
b.w.) and oleuropein (20 mg/kg b.w.) group;  
°p < 0.01 vs. S subgroup and baseline, *p < 0.01 vs. I group. 
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4.2 The clinical study 
4.2.1 Nutritional status evaluation 
Under baseline conditions, all obese patients showed significant 
differences in anthropometric measurements compared to normal weight ones. 
In particular, patients belonging to O and HO groups had a significant higher 
waist circumference, indicating an increased cardiovascular risk for these 
women (Table 4.2).   Moreover, hyperlipidemic females showed an alterated 
lipid profile, with higher total cholesterol, LDL cholesterol and triglycerides 
levels, compared to obese and normal weight controls (Table 4.2). 
After three months of hypocaloric and hypolipidic diet all obese 
patients showed a significant reduction in BMI and anthropometric parameters, 
as well as an improvement in body composition (Tables 4.2.1.).  
Furthermore, after three months dieting, a significant decrease in total 
serum cholesterol, LDL cholesterol and triglycerides was detected in OD and 
OL groups (Table 4.2.2). However, the reduction in total and LDL cholesterol 
appeared higher in patients treated with oleuropein, compared to 
hyperlipidemic controls (Table 4.2.2). After three months, indeed, Total and 
LDL cholesterol reduced by 15.0 ±1.2 % and 16.5 ±1.3 % in OD group, treated 
with the only diet, and by 21.3±1.5 % and 21.2±1.4 % in OL group, treated 
with diet plus oleuropein (Fig.4.2, 4.2.1). Moreover, we did not observed 
significant changes in serum GOT and GPT in all groups (data not shown). 
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4.2.2 SBF evaluation under resting conditions 
Under baseline conditions, laser Doppler signals revealed significant 
differences between normal weight, obese and hyperlipidemic obese patients. 
HO and O groups showed lower perfusion values compared to normal weight 
one even though the skin blood flow of hyperlipidemic patients was lower 
compared to obese subjects (8.0±0.5 vs 9.1±0.6 vs 12.0±0.5 PU; p<0.01 vs O 
and NW groups; Fig.4.2.2). Moreover, the spectral analysis revealed that total 
PSD was lower in obese and hyperlipidemic females compared to normal 
weight ones (65.0±4.1 vs 127.3±6.0 vs 200.5±5.5 PU2/Hz; p<0.01 vs O and 
NW groups; Fig.4.2.3). The wavelet analysis was applied to all Laser Doppler 
signals revealing six frequency components in the range between 0.005 and 2 
Hz, as previously reported [96]. Under baseline conditions, the power spectral 
density of neurogenic and myogenic activities appeared higher than those 
related to other parameters, however, the myogenic activity, expressed as 
percent of the total power spectral density, appeared significantly lower in 
hyperlipidemic obese females compared to obese and normal weight patients 
(25.4 ± 1.5 vs 30.8 ± 2.0 and 36.0 ± 2.6 %, p<0.01 vs O and NW groups; 
Fig.4.2.4). On the other hand, the frequency component related to the 
respiration was higher in HO group, compared to normolipidemic obese and 
normalweight controls (12.5±1.3 vs 10.2±1.1 vs 9.8±0.9 %, p<0.01 vs O and 
NW groups). 
 
4.2.3 SBF evaluation after three months dieting  
After three months of hypocaloric and hypolipidic diet all 
hyperlipidemic obese patients showed a significant improvement in SBF 
(Fig.4.2.5) and total PSD of LDPM oscillations. In particular, SBF increased 
by 25.6 ±1.4 % of baseline in patients administered with oleuropein plus 
dieting, while the increase appeared lower in OD group (+12.5±1.2 %, p<0.01 
vs T0). Moreover, total PSD of LDPM signals significantly increased in both 
groups even though we did not detect significant differences between OD and 
OL groups.  
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Furthermore, the spectral analysis of skin blood flow oscillations 
revealed significant changes compared to baseline conditions. After weight 
reduction OD as well as OL groups showed a significant increase in the 
myogenic related component, compared to baseline values (29.7 ± 2.5 vs 25.4 
± 1.5 % and 35.8±3.2 vs 24.6±1.5, p<0.01 vs T0; Fig. 4.2.6, 4.2.7). 
Interestingly, OL group showed higher percentage increase in the myogenic-
related frequency component, compared to OD one (Fig.4.2.7). This change in 
the total power spectrum was accompanied by a significant decrease in the 
respiratory-related frequency component and a significant increase in NO-
dependent frequency component, compared to baseline conditions (Fig.4.2.7.).  
4.2.4 PORH evaluation 
Under baseline conditions, the hyperemic response was significantly 
lower in HO and O groups, compared to NW one: in particular, we detected 
differences in all studied parameters, such as PK(max), Tp and PK (%) (Table 
4.2.3). Moreover, the peak value was lower in hyperlipidemic obese subjects 
than in normolipidemic ones (31.1±2.8 vs 37.3± 2.6 and 59.1±2.3 PU, 
respectively; p<0.01 vs O and NW groups) as well as the percent increase from 
baseline (402.9±3.8 vs 528.8±6.4 and 769.9±8.0 %, respectively; p<0.01 vs O 
and NW groups), and the time to peak (12.5±0.6 vs 9.1±0.7 and 7.0± 0.8 
seconds, respectively; p<0.01 vs O and NW group; Table 4.2.3.). 
After three months of dietary treatment a significant improvement in 
hyperemic response was detected in all obese subjects, compared to baseline 
conditions. In particular, OD and OL groups showed a significant increase in 
peak value (46.5±3.1 vs 29.9±2.4 and 65.2±2.3 vs 32.3±2.8 PU, respectively, 
p<0.01 vs T0; Fig. 4.2.8.) and in total percent increase from baseline 
(616.3±4.6 vs 405.5±3.0 and 749.1±4.0 vs 402.2±4.7%, respectively; p<0.01 
vs T0; Fig. 4.2.9.); on the other hand the time to peak significantly reduced, 
compared to baseline conditions (7.4± 0.5 vs 12.7 ± 0.4 and 9.3±0.6 vs 12.3± 
0.8 seconds, in OD and OL groups respectively; p<0.01 vs T0; Figure 4.2.10).  
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 NW GROUP 
(n=20) 
O GROUP 
(n=20) 
HO GROUP 
(n=40) 
  T0 T0 T0 
BMI (kg/m
2
) 23.5±1.2 34.81.1* 35.00.5* 
WC (cm) 84.1±1.3 105.71.6* 105.11.2* 
HC (cm) 97.4±1.4 113.82.0* 113.01.8* 
TS (mm) 17.5±1.3 31.31.6* 31.41.4* 
FM (%) 31.6±1.3 41.51.3* 39.91.1* 
FFM (%) 68.4±1.5 58.71.9* 59.71.4* 
Total cholesterol 
(mg/dL) 
184.6±3.6 191.21.5 255.73.7*° 
HDL cholesterol 
(mg/dL) 
60.62.4 58.62.8 52.22.5 
LDL cholesterol  
(mg/dL) 
113.7±2.4 122.62.3 173.74.3*° 
Triglycerides 
(mg/dL) 
130.5±4.1 132.13.5 
  
180.24.1*° 
 
Table 4.2.: Anthropometric measurements [body mass index (BMI), waist 
circumference (WC), hip circumference (HF) and triceps skinfold (TS)], body 
composition [Fat Mass (FM) and Fat Free Mass (FFM)] and metabolic parameters 
[Total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides] under baseline 
conditions (T0) in normalweight (NW), normolipidemic obese (O group) and 
hyperlipidemic obese (HO group) patients. 
Data are reported as mean ± SEM. 
*p<0.01 vs NW group; °p<0.01 vs O group. 
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 OD GROUP OL GROUP 
  T0 T1 T0 T1 
BMI (kg/m
2
) 36.20.4 31.90.6* 34.20.5 31.70.4 * 
WC (cm) 104.91.4 99.21.1* 105.41.3 98.91.2* 
HC (cm) 112.61.8 109.82.2° 113.51.6 111.01.7 
TS (mm) 29.81.3 26.81.2* 33.01.5 31.41.5* 
FM (%) 42.21.3 39.91.4* 37.60.9 35.51.3* 
FFM (%) 57.01.9 58.31.9 62.40.9 64.51.3* 
 
 
 
Table 4.2.1.: Anthropometric measurements [body mass index (BMI), waist 
circumference (WC), hip circumference (HF) and triceps skinfold (TS)], body 
composition [Fat Mass (FM) and Fat Free Mass (FFM)] and metabolic parameters 
[Total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides under baseline 
conditions (T0) and after three months dieting in oleuropein-treated group (OL) and 
hyperlipidemic controls (OD). 
Data are reported as mean ± SEM. 
*p<0.01 vs T0; °p<0.05 vs T0  
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 OD GROUP OL GROUP  
 
  T0 T1 Δ T0 T1 Δ 
Total 
cholesterol 
(mg/dL) 
255.03.4 216.93.6* -38.1 256.53.2 202.03.3*+ -54.5 
HDL 
cholesterol 
(mg/dL) 
56.62.0 51.42.4 -5.2 47.83.0 44.23.1 -3.6 
LDL 
cholesterol  
(mg/dL) 
168.43.5 140.62.4* -27.8 179.04.2 141.22.5*+ -37.8 
Triglycerides 
(mg/dL) 
193.84.3 156.24.0* -37.6 166.74.5 126.43.8* -40.3 
 
 
 
 
Table 4.2.2.: Total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides 
under baseline conditions (T0) and after three months dieting (T1) in oleuropein-treated 
group (OL) and hyperlipidemic controls (OD). 
Data are reported as mean ± SEM. 
*p<0.01 vs T0; °p<0.05 vs T0 ; +p<0.01 vs OD (T0) 
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Fig. 4.2.: Total cholesterol, LDL cholesterol and HDL cholesterol under 
baseline conditions (T0) and after three months of hypocaloric and hypolipidic 
diet in OD group. 
*p<0.01 vs T0. 
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Fig. 4.2.1.: Total cholesterol, LDL cholesterol and HDL cholesterol 
under baseline conditions (T0) and after three months of hypocaloric and 
hypolipidic diet plus oleuropein in OL group. 
*p<0.01 vs T0. 
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Fig.4.2.2.: Skin microvascular blood flow, expressed as Perfusion Units 
(PU), under baseline conditions (T0) in normal weight (NW group), 
normolipidemic obese (O group) and hyperlipidemic obese subjects (HO 
group). 
*p<0.01 vs NW group; 
°p<0.01 vs O group. 
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Fig.4.2.3.: Total Power Spectral Density, expressed as PU2/Hz, under 
baseline conditions (T0) in normalweight (NW group), normolipidemic obese 
(O group) and hyperlipidemic obese subjects (HO group). 
*p<0.01 vs NW group, °p<0.01 vs O group 
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Fig.4.2.4.: Normalized power spectral density, expressed as percent, 
related to NO-independent endothelial activity (1), NO-dependent endothelial 
activity (2), neurogenic activity (3), myogenic activity (4), respiration (5) and 
heart rate (6) under baseline conditions (T0) in normal weight (NW), 
normolipidemic obese (O) and hyperlipidemic obese patients (HO).  
* p< 0.01 vs T0 NW group, ° p< 0.01 vs T0 O group. 
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Fig.4.2.5.: Skin microvascular blood flow, expressed as Perfusion Units 
(PU), under baseline conditions (T0) and after three months of hypocaloric and 
hypolipidic diet (T1), in hyperlipidemic obese controls (OD group) and 
oleuropein-treated group (OL group). 
*p<0.01 vs T0 
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Fig.4.2.6.: Normalized power spectral density, expressed as percent, 
related to NO-independent endothelial activity (1), NO-dependent endothelial 
activity (2), neurogenic activity (3), myogenic activity (4), respiration (5) and 
heart rate (6) under baseline conditions (T0) and after three months of 
hypocaloric and hypolipidic diet in hyperlipidemic obese controls (OD group). 
* p< 0.01 vs T0  
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Fig.4.2.7.: Normalized power spectral density, expressed as percent, 
related to NO-independent endothelial activity (1), NO-dependent endothelial 
activity (2), neurogenic activity (3), myogenic activity (4), respiration (5) and 
heart rate (6) under baseline conditions (T0) and after three months of 
hypocaloric and hypolipidic diet (T1) in oleuropein-treated group (OL group). 
* p< 0.01 vs T0  
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Groups PK  
(PU) 
PORH 
(%) 
Tp  
(sec) 
Duration of 
hyperemia 
(sec) 
NW 59.1±2.3 767.2±8.0 7.0±0.8 49.2±2.9 
O 37.3±2.6* 525.5±6.4* 9.1±0.7° 41.5±3.4° 
HO 31.1±2.8*+ 402.2±3.8*+ 12.5±0.6*+ 37.1±3.1* 
 
 
 
Table 4.2.3: Post-occlusive reactive hyperemia (PORH) peak (PK), 
expressed as perfusion units (PU); PORH total increase, expressed as percent 
(%); time to peak (Tp), expressed as seconds (sec); duration of hyperemia 
(sec), under baseline conditions in NW, O and HO groups. 
* p< 0.01 vs T0 NW group; °p<0.05 vs T0 NW group; +p<0.01 vs T0 O group 
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Fig.4.2.8.: Post-occlusive reactive hyperemia peak, expressed as 
perfusion units (PU), under baseline conditions (T0) and after three months of 
hypocaloric and hypolipidic diet (T1) in OD and OL groups.  
*p<0.01 vs T0. 
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Fig.4.2.9.: Percent increase in post-occlusive reactive hyperemia, under 
baseline conditions (T0) and after three months of hypocaloric and hypolipidic 
diet (T1) in OD and OL groups.  
*p<0.01 vs T0. 
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Fig.4.2.10.: Time to peak, expressed in seconds, under baseline 
conditions (T0) and after three months of hypocaloric and hypolipidic diet (T1) 
in OD and OL groups.  
* p< 0.01 vs T0  
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Chapter 5 
Discussion  
The results of the present study indicate that oleuropein was able to 
improve microvascular functions in rats and humans. It is well known, indeed, 
that 30 min of hypoperfusion and 60 min of reperfusion in rat brain induce 
significant microvascular alterations, characterized by a decrease in arteriolar 
diameter, increase in microvascular leakage, leukocyte adhesion to venules and 
reduction in capillary perfusion, as previously reported [122]. The in vivo study 
allowed us to visualize the pial arteriolar tree characterizing the microvascular 
networks on the brain surface, where the arterioles are involved in the vascular 
resistance regulation, according to their geometric features. The significant 
reduction in diameter, observed in order 3 arterioles at the end of reperfusion, 
in hypoperfused rats, was accompanied by an increase in microvascular 
leakage, indicated by FD70 extravasation from vessels to the interstitium, and 
by leukocyte adhesion to venular wall. These alterations are representative of 
the blood brain barrier damage and tissue perfusion reduction.  
Interestingly, oleuropein, a polyphenol widely diffused in olive plants 
derivatives, protected rat pial microcirculation after BCCAO and reperfusion. 
Previous studies indicate that oleuropein shows several anti-oxidant and anti-
inflammatory properties. This molecule is able, indeed, to reduce LDL 
oxidation and plasmatic cholesterol levels in rabbits as well as to protect 
isolated rat hearts from ischemia-reperfusion injury, reducing creatine kinase 
production and the reduced glutathione release [41,42]. Moreover, oleuropein 
appears able to inhibit the biosynthesis of several pro-inflammatory cytokines, 
such as tumor necrosis factor α (TNF-α) and interleukin-1 beta (IL-1β) [43].  
In our study, at the end of BCCAO, 20 mg/kg b.w. oleuropein abolished 
the decrease in diameter in all arteriolar orders and prevented microvascular 
leakage, compared to hypoperfused animals.  LDF measurements confirmed 
these data indicating that pial blood flow appeared higher in treated animals, 
compared to hypoperfused controls. At the end of reperfusion, oleuropein 
higher dosage induced a strong arteriolar vasodilation increasing the blood 
flow by 28 ± 2% of baseline. These vasodilatory effects were abolished by L-
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NIO, a specific eNOS inhibitor, administered prior to oleuropein, indicating 
that this polyphenol could induce e-NOS expression and NO release from 
endothelial cells. Furthermore, oleuropein acute administration reduced 
leukocyte adhesion to venules, at the end of reperfusion, decreasing the 
inflammatory response. Rats treated with oleuropein showed higher eNOS 
expressions, both total and phosphorylated proteins, in the cerebral cortex as 
well as in the striatum, indicating that this compound was able to enhance NO 
release. Moreover, oleuropein prevented oxidative stress reducing the ischemic 
damage and protecting capillary perfusion.  
To investigate oleuropein effects on human microcirculation, we 
measured the skin blood perfusion levels in hyperlipidemic obese patients by 
LDF. It is well known, indeed, that obesity and hyperlipidemia induce changes 
in microvascular function long before the formation of fatty streak lesions in 
large arteries [113,114]. In particular, LDF is a non-invasive technique 
allowing us to detect real-time changes in skin microvascular perfusion levels 
under baseline conditions as well as after acute stimuli, such as brachial artery 
occlusion. We chose to analyze cutaneous microcirculation because the skin is 
an easily accessible organ and its microvascular alterations can reflect the 
changes in other vascular beds, such as the cardiac one [123,124]. 
Interestingly, Stefanovska and coworkers demonstrated that skin blood 
flow oscillations can be analyzed by spectral methods to receive informations 
about the different local and central mechanisms regulating blood flow. 
Spectral analysis of LDF signals, indeed, reveals six different frequency 
intervals in the range between 0.005–2.0 Hz. These oscillations have been 
related to the influence of NO-independent and NO-dependent endothelial 
activities, sympathetic nervous system discharge, intrinsic myogenic activity of 
vascular smooth muscle cells, respiration and heart rate, as previously reported 
[94-96].  
Under baseline conditions, all obese patients showed lower perfusion 
values, compared to normalweight ones, even though the skin blood flow 
appeared particularly low in hyperlipidemic subjects. These results confirm 
that obesity and hyperlipidemia affect arteriolar tone and tissue perfusion 
[101,102, 117-119]. In our study, the application of spectral analysis to LDF 
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signals showed that the power spectral density of frequency components 
related to neurogenic and myogenic activities were the predominant 
components of the total power spectrum, in all subjects. These data indicate 
that sympathetic nervous system discharge and the activity of smooth muscle 
cells were mainly involved in the regulation of microvascular blood flow 
distribution. However, normolipidemic obese subjects, as well as 
hyperlipidemic ones, were characterized by a significant decrease in the 
myogenic-related frequency component, compared to normalweight patients. 
These data are in accord with previous data, suggesting that obesity impairs 
smooth muscle cell tone.  Interestingly, the activity of smooth muscle cells 
appeared lower in hyperlipidemic obese subjects, compared to normolipidemic 
obese controls. Therefore, it is possible to hypothesize that hyperlipidemia, 
associated to obesity, further affects smooth muscle cells activity increasing 
arteriolar stiffness in these patients. We detected also an increased respiratory-
related frequency component in hyperlipidemic obese group, compared to 
controls, probably due to an increase in respiratory central drive on the 
microvascular blood flow.  
Microvascular functions were further investigated evaluating the post-
occlusive reactive hyperemia (PORH) in all patients. All obese females showed 
a reduced hyperemic response, compared to normalweight group, while 
hyperlipidemic subjects showed lower values. Therefore, our results indicate 
that obesity and hyperlipidemia altered microvascular function under baseline 
conditions as well as after acute stimulation, reducing the dilatory reserve of 
arterial vessels. 
After three months dieting, all hyperlipidemic obese patients showed 
improvements in anthropometric measurements and body composition. 
Moreover, serum lipid profile of hyperlipidemic patients significantly 
improved, compared to baseline conditions. Interestingly, total and LDL 
cholesterol decreased by 21.3±1.5 and 21.2±1.4% of baseline in oleuropein-
treated group and by 15.0±1.2 and 16.5±1.3% of baseline in hyperlipidemic 
controls. These results are in accord with several in vivo studies suggesting that 
oleuropein is able to improve lipid profile [41]. These changes in nutritional 
status and lipid profile were accompanied by an improvement in perfusion 
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values and skin blood flow oscillations, after three months treatment. We 
detected, indeed, significant changes in the total power spectral density of both 
groups patients. In particular, evaluating the frequency components of blood 
flow oscillations, the myogenic-related frequency component significantly 
increased in both groups, even though the increase was higher in oleuropein-
treated group, compared to controls. Furthermore, the high frequency 
component related to respiration significantly decreased, while the spectral 
density of the NO-dependent frequency component significantly increased in 
oleuropein-treated group. These results indicate that the amplitude of blood 
flow oscillations increased after oleuropein administration, due to the 
improvement in endothelial and myogenic activities. At the same time, there 
was a reduction in the respiratory central drive influence on peripheral blood 
flow. These effects may indicate a higher activity of vascular endothelial and 
smooth muscle cells. 
Moreover, these patients showed an improvement in hyperemic 
response, suggesting a recovery in endothelial and smooth muscle cell 
functions. However, it is important to point out that reactive hyperemia results 
from the interplay of several regulatory mechanisms, such as metabolic and 
endothelial vasodilators, the myogenic response and sympathetic nervous 
system discharge. Among endothelial vasodilators, NO, EDHF and 
prostaglandins, particularly prostacyclin, are mainly implicated in human skin 
hyperemic response [133,134]. Therefore, the evaluation of reactive hyperemia 
by LDF represents an useful non-invasive tool in evaluating the global 
microvascular function [135].  
We know there are several non-invasive methods to investigate vascular 
function. Among these, the evaluation of flow mediated dilation (FMD) by 
ultrasound has been widely used in the clinical research to investigate 
endothelial dysfunction under several pathological conditions. This method, 
introduced in 1992, allow one to measure brachial artery diameter changes 
after ischemic stimulation. The acute stimulation induces nitric oxide release 
from endothelium determining a vasodilation that can be assessed and 
visualized by ultrasound imaging. The brachial artery is observed above the 
antecubital fossa in the longitudinal plane. In particular, a segment with clear 
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anterior and posterior intimal interfaces between the lumen and vessel wall is 
selected for continuous 2D grayscale imaging, as previously reported. FMD 
has been widely used in the clinical practice demonstrating the presence of 
endothelial dysfunction in many pathological conditions, such as diabetes and 
hypertension. It is worth noting that the reproducibility of reactive hyperemia 
by LDF is similar to that of brachial artery by flow-mediated dilation, as 
previously reported [136,137]. Moreover, many studies report a significant 
correlation between FMD and LDF measurements. However, variations in 
arteries smaller than 2.5 mm in diameter are difficult to measure by FMD 
[136]. Therefore, cutaneous LDF may represent a simple, non-invasive tool to 
assess microvascular function in the daily practice. 
In the present study, we focused our attention on skin microcirculation 
because these peripheral arteriolar networks are mainly involved in the 
regulation of blood flow distribution. Several studies investigated the 
flowmotion by LDF under different pathological conditions, such as 
hypertension, diabetes and hypercholesterolemia indicating an impaired flow-
dependent vasodilation [61,62].  Moreover, the application of spectral analysis 
to the skin blood flow oscillations reveals that three months dieting plus 
oleuropein improved the activity of smooth muscle cells and NO release from 
endothelial cells.   
In conclusion, oleuropein appears able to improve microvascular 
function in rats increasing NO release from endothelial cells, reducing ROS 
production and facilitating tissue perfusion. Moreover, this polyphenol, 
associated to dieting, appears able to improve serum lipid profile and tissue 
perfusion in hyperlipidemic obese females.  
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